醫學專欄~黃柏翰-異位性皮膚炎處理之新進展：台灣皮膚科醫學會治療共識之再解讀

1. 2014
27
75%
1
84%
------------------------------------------------------
First line treatment
• Emollients
• Topicl corticosteroids
• Antihistamines
• Therapeutic patient education
Second line treatment
• Topicl calcineurin inhibitors
• Burst use of systemic conticosteroids
• Phototherapy
• Topicl and systemic antibiotics
Third line treatment
• Systemic immunomodulatory agents
• Antiseptics
• Alternative medicine
------------------------------------------------------
wet-wrap therapy(
)
2

2. (
Fluticasone) 44
:
?

3. 89%
AI
3
pimecrolimus tacrolimus
tacrolimus 0.1% proactive
treatment
4
burst systemic steroid
(3-7 ) (
10-15 mg/d )4
3-7
burst 4
broad-band UVB
narrow-band UVB UVA1
8

4. PUVA
(non-melanoma skin cancer)
(melanoma)
narrow-band UVB
4
8
(
8
)
dicloxacillin
cephalexin
ORSA trimethoprim-sulfamet
hoxazole rifampicin fucidic acid mupir
ocin
cyclosporine
2.5mg/
kg/d dose-related
3mg/kg/d
Methotrexate (10-22.5 mg/week)
azathioprine (1.5~2.5 mg/d)
cyclosporine
azathioprine
azthioprine cyclosporine
myelosuppression
1
(diluted bleach baths) 5
Amy
Paller
1:1500

5. wet wraps